Thiamine hydrochloride

DRUG4 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Menzies School of Health Research, Beth Israel Deaconess Medical Center

Conditions

HIV InfectionsKidney InjurySepsisThiamine DeficiencyWernicke-Korsakoff Syndrome

Phase 2

Thiamine as a Renal Protective Agent in Septic Shock

CompletedNCT03550794

Beth Israel Deaconess Medical CenterKidney Injury, Sepsis, Thiamine Deficiency

Start: 2018-09-04End: 2022-04-05Updated: 2023-06-27

Phase 4

Optimum Thiamine Intervention (OpTIn) Trial

CompletedNCT02788552

Menzies School of Health ResearchWernicke-Korsakoff Syndrome

Start: 2014-09-30End: 2019-08-01Updated: 2019-08-16

Unknown Phase

Vitamin B Therapy for Hyperlactatemia

CompletedNCT00031057

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Target: 225Updated: 2011-02-28

A Study to See if Certain Antioxidants and Vitamins Will Keep Lactate Levels Down in Patients Taking Anti-HIV Drugs

WithdrawnNCT00037063

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Updated: 2015-06-04

Related Papers

Thiamine administration in septic shock: a post hoc analysis of two randomized trials.

2024-02-0613 citations

Thiamine for Renal Protection in Septic Shock (TRPSS): A Randomized, Placebo-controlled, Clinical Trial.

2023-09-0117 citations